NASDAQ:PVLA | Insider Transactions | PALVELLA THERAPEUTICS, INC.

PVLA Insider Transactions

106 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–100; provenance stays internal.

PVLA insiders transaction timeline

PurchaseSale
2015-07-06: 8 purchases — ISALY SAMUEL D, ORBIMED ADVISORS LLC, OrbiMed Capital GP III LLC and 1 more2016-06-13: 3 purchases — DEPTULA-HICKS DARLENE M, Yoder Stephen S., Matis Louis2016-06-14: 1 purchase — Matis Louis2017-08-16: 1 purchase — Reine Allan2017-08-17: 2 purchases — GERAGHTY JAMES A, Reine Allan2017-12-18: 6 sales — ISALY SAMUEL D, ORBIMED ADVISORS LLC, OrbiMed Capital GP III LLC2018-01-03: 6 sales — ISALY SAMUEL D, ORBIMED ADVISORS LLC, OrbiMed Capital GP III LLC2018-02-13: 4 sales — ORBIMED ADVISORS LLC, OrbiMed Capital GP III LLC2018-04-30: 4 sales — ORBIMED ADVISORS LLC, OrbiMed Capital GP III LLC2018-05-15: 1 purchase — GERAGHTY JAMES A2018-09-14: 1 purchase — KIRITSY CHRISTOPHER P2019-09-06: 21 sales — BIOTECHNOLOGY VALUE FUND L P, BVF PARTNERS L P/IL, BVF INC/IL and 4 more2020-07-21: 1 sale — Aquilo Capital Management, LLC2021-08-30: 2 sales — Olwill Shane2022-05-13: 1 purchase — Demuth Tim2023-05-25: 1 purchase — KIRITSY CHRISTOPHER P2024-08-07: 1 purchase — GERAGHTY JAMES A2024-08-09: 2 purchases — ADAR1 Partners, LP, ADAR1 Capital Management, LLC2024-08-12: 4 purchases — ADAR1 Partners, LP, ADAR1 Capital Management, LLC2024-12-18: 1 purchase — JENKINS GEORGE M2025-04-09: 2 purchases — JENKINS GEORGE M2025-11-19: 2 sales — Goin Kathleen2025-12-17: 1 sale — Goin Kathleen2026-01-21: 2 sales — Goin Kathleen2026-02-18: 2 sales — Goin Kathleen2026-02-27: 2 purchases — JENKINS GEORGE M, HERON ELAINE J2026-03-18: 3 sales — Goin Kathleen2026-03-30: 1 purchase — JENKINS GEORGE M2026-04-15: 5 sales — Goin Kathleen2026-05-20: 3 sales — Goin Kathleen2026-06-17: 3 sales — Goin Kathleen2026-07-15: 4 sales — Goin Kathleen2026-08-19: 5 sales — Goin Kathleen2015-07-062026-08-19
Insider profileRoleDateTransactionSharesPrice
Goin KathleenChief Operating Officer2026-08-19Sale302$156.77
Goin KathleenChief Operating Officer2026-08-19Sale102$155.5898
Goin KathleenChief Operating Officer2026-08-19Sale400$152.9975
Goin KathleenChief Operating Officer2026-08-19Sale1,998$151.7979
Goin KathleenChief Operating Officer2026-08-19Sale1,500$151.39
Goin KathleenChief Operating Officer2026-07-15Sale1,911$150.2529
Goin KathleenChief Operating Officer2026-07-15Sale1,029$149.2667
Goin KathleenChief Operating Officer2026-07-15Sale840$148.4018
Goin KathleenChief Operating Officer2026-07-15Sale522$147.1365
Goin KathleenChief Operating Officer2026-06-17Sale25.0$112.23
Goin KathleenChief Operating Officer2026-06-17Sale1,887.0$111.31
Goin KathleenChief Operating Officer2026-06-17Sale2,390.0$110.26
Goin KathleenChief Operating Officer2026-05-20Sale48.0$111.9
Goin KathleenChief Operating Officer2026-05-20Sale891.0$111.3
Goin KathleenChief Operating Officer2026-05-20Sale3,363.0$110.35
Goin KathleenChief Operating Officer2026-04-15Sale100.0$130.33
Goin KathleenChief Operating Officer2026-04-15Sale639.0$129.17
Goin KathleenChief Operating Officer2026-04-15Sale561.0$128.23
Goin KathleenChief Operating Officer2026-04-15Sale1,500.0$127.13
Goin KathleenChief Operating Officer2026-04-15Sale1,502.0$125.96
JENKINS GEORGE MDirector2026-03-30Purchase445.0$112.3
Goin KathleenChief Operating Officer2026-03-18Sale304.0$119.08
Goin KathleenChief Operating Officer2026-03-18Sale1,730.0$118.37
Goin KathleenChief Operating Officer2026-03-18Sale2,268.0$117.56
JENKINS GEORGE MDirector2026-02-27Purchase4,000.0$125.0
HERON ELAINE JDirector2026-02-27Purchase2,400.0$125.0
Goin KathleenChief Operating Officer2026-02-18Sale1,276.0$79.97
Goin KathleenChief Operating Officer2026-02-18Sale3,026.0$79.16
Goin KathleenChief Operating Officer2026-01-21Sale3,749.0$97.94
Goin KathleenChief Operating Officer2026-01-21Sale553.0$95.49
Goin KathleenChief Operating Officer2025-12-17Sale4,302.0$96.47
Goin KathleenChief Operating Officer2025-11-19Sale2,802.0$86.51
Goin KathleenChief Operating Officer2025-11-19Sale1,500.0$85.72
JENKINS GEORGE MDirector2025-04-09Purchase2,490.0$20.27
JENKINS GEORGE MDirector2025-04-09Purchase2,500.0$20.13
JENKINS GEORGE MDirector2024-12-18Purchase4,000.0$12.93
ADAR1 Partners, LPTenPercentOwner2024-08-12Purchase757.0$15.88
ADAR1 Capital Management, LLCTenPercentOwner2024-08-12Purchase757.0$15.88
ADAR1 Partners, LPTenPercentOwner2024-08-12Purchase2,243.0$15.88
ADAR1 Capital Management, LLCTenPercentOwner2024-08-12Purchase2,243.0$15.88
ADAR1 Partners, LPTenPercentOwner2024-08-09Purchase3,000.0$14.89
ADAR1 Capital Management, LLCTenPercentOwner2024-08-09Purchase3,000.0$14.89
GERAGHTY JAMES ADirector2024-08-07Purchase1.0$1.0
KIRITSY CHRISTOPHER PDirector2023-05-25Purchase10,000.0$0.85
Demuth TimChief Medical Officer2022-05-13Purchase6,000.0$1.71
Olwill ShaneChief Development Officer2021-08-30Sale29,200.0$5.15
Olwill ShaneChief Development Officer2021-08-30Sale9,200.0$5.0
Aquilo Capital Management, LLCTenPercentOwner2020-07-21Sale1,900,000.0$2.95
BIOTECHNOLOGY VALUE FUND L POther2019-09-06Sale1,128.0$4.5
BVF PARTNERS L P/ILTenPercentOwner2019-09-06Sale1,128.0$4.5
BVF INC/ILTenPercentOwner2019-09-06Sale1,128.0$4.5
BIOTECHNOLOGY VALUE FUND II LPOther2019-09-06Sale1,128.0$4.5
LAMPERT MARK NTenPercentOwner2019-09-06Sale1,128.0$4.5
Biotechnology Value Trading Fund OS LPOther2019-09-06Sale1,128.0$4.5
BVF Partners OS Ltd.Other2019-09-06Sale1,128.0$4.5
BIOTECHNOLOGY VALUE FUND L POther2019-09-06Sale25,720.0$4.5
BVF PARTNERS L P/ILTenPercentOwner2019-09-06Sale25,720.0$4.5
BVF INC/ILTenPercentOwner2019-09-06Sale25,720.0$4.5
BIOTECHNOLOGY VALUE FUND II LPOther2019-09-06Sale25,720.0$4.5
LAMPERT MARK NTenPercentOwner2019-09-06Sale25,720.0$4.5
Biotechnology Value Trading Fund OS LPOther2019-09-06Sale25,720.0$4.5
BVF Partners OS Ltd.Other2019-09-06Sale25,720.0$4.5
BIOTECHNOLOGY VALUE FUND L POther2019-09-06Sale23,152.0$4.5
BVF PARTNERS L P/ILTenPercentOwner2019-09-06Sale23,152.0$4.5
BVF INC/ILTenPercentOwner2019-09-06Sale23,152.0$4.5
BIOTECHNOLOGY VALUE FUND II LPOther2019-09-06Sale23,152.0$4.5
LAMPERT MARK NTenPercentOwner2019-09-06Sale23,152.0$4.5
Biotechnology Value Trading Fund OS LPOther2019-09-06Sale23,152.0$4.5
BVF Partners OS Ltd.Other2019-09-06Sale23,152.0$4.5
KIRITSY CHRISTOPHER PDirector2018-09-14Purchase5,000.0$5.11
GERAGHTY JAMES ADirector2018-05-15Purchase10,000.0$5.75
ORBIMED ADVISORS LLCTenPercentOwnerOther2018-04-30Sale10,400.0$6.35
OrbiMed Capital GP III LLCTenPercentOwnerOther2018-04-30Sale10,400.0$6.35
ORBIMED ADVISORS LLCTenPercentOwnerOther2018-04-30Sale989,600.0$6.35
OrbiMed Capital GP III LLCTenPercentOwnerOther2018-04-30Sale989,600.0$6.35
ORBIMED ADVISORS LLCTenPercentOwner2018-02-13Sale75.0$8.98
OrbiMed Capital GP III LLCTenPercentOwner2018-02-13Sale75.0$8.98
ORBIMED ADVISORS LLCTenPercentOwner2018-02-13Sale7,822.0$8.98
OrbiMed Capital GP III LLCTenPercentOwner2018-02-13Sale7,822.0$8.98
ISALY SAMUEL DTenPercentOwner2018-01-03Sale16,128.0$7.35
ORBIMED ADVISORS LLCTenPercentOwner2018-01-03Sale16,128.0$7.35
OrbiMed Capital GP III LLCTenPercentOwner2018-01-03Sale16,128.0$7.35
ISALY SAMUEL DTenPercentOwner2018-01-03Sale1,693,492.0$7.35
ORBIMED ADVISORS LLCTenPercentOwner2018-01-03Sale1,693,492.0$7.35
OrbiMed Capital GP III LLCTenPercentOwner2018-01-03Sale1,693,492.0$7.35
ISALY SAMUEL DTenPercentOwner2017-12-18Sale1,392.0$5.7
ORBIMED ADVISORS LLCTenPercentOwner2017-12-18Sale1,392.0$5.7
OrbiMed Capital GP III LLCTenPercentOwner2017-12-18Sale1,392.0$5.7
ISALY SAMUEL DTenPercentOwner2017-12-18Sale146,243.0$5.7
ORBIMED ADVISORS LLCTenPercentOwner2017-12-18Sale146,243.0$5.7
OrbiMed Capital GP III LLCTenPercentOwner2017-12-18Sale146,243.0$5.7
GERAGHTY JAMES ADirector2017-08-17Purchase10,000.0$4.82
Reine AllanSee Remarks2017-08-17Purchase20,000.0$4.89
Reine AllanSee Remarks2017-08-16Purchase45,000.0$4.79
Matis LouisSVP, Chief Development Officer2016-06-14Purchase7,915.0$1.71
DEPTULA-HICKS DARLENE MSVP, Chief Financial Officer2016-06-13Purchase5,000.0$1.66
Yoder Stephen S.President and CEO2016-06-13Purchase6,000.0$1.68
Matis LouisSVP, Chief Development Officer2016-06-13Purchase2,085.0$1.68
ISALY SAMUEL DDirector,TenPercentOwner2015-07-06Purchase4,717.0$2.75
ORBIMED ADVISORS LLCDirector,TenPercentOwner2015-07-06Purchase4,717.0$2.75